Isothermal microcalorimetry to study drugs against Schistosoma mansoni

Manneck, T. and Braissant, O. and Haggenmüller, Y. and Keiser, J.. (2011) Isothermal microcalorimetry to study drugs against Schistosoma mansoni. Journal of clinical microbiology, Vol. 49, H. 4. pp. 1217-1225.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6002257

Downloads: Statistics Overview


Background: Alternative antischistosomal drugs are required since praziquantel is virtually the only drug available for treatment and morbidity control of schistosomiasis. Manual microscopic reading is the current gold standard to assess the in vitro antischistosomal properties of test drugs, however it is labor intensive, subjective and difficult to standardize. Hence, there is a need to develop novel tools for antischistosomal drug discovery. Methods: The in vitro effect of praziquantel, oxamniquine, artesunate and mefloquine on metabolic activity and parasite motility of Schistosoma mansoni (newly transformed schistosomula (NTS) and 49 day-old adult worms) were studied using isothermal microcalorimetry (IMC). Results were compared to morphological readouts of viability. Results: Results obtained for the 4 drugs tested with phenotypic evaluation by microscopy and IMC showed a good correlation, but IMC also identified drug effects, which were not visible by microscopic evaluation, and IMC precisely determined the onset of action of the test drugs. Similar sensitivities on NTS and adult schistosomes were observed for praziquantel and mefloquine, while slight differences in the drug susceptibilities of the two development stages were noted with oxamniquine and artesunate. Conclusion: IMC is a useful tool for antischistosomal drug discovery, which should be further validated. In addition, our data support the use of NTS in in vitro schistosome drug assays
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Klinische Pharmakologie
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Klinische Pharmakologie
09 Associated Institutions > Swiss Tropical and Public Health Institute (Swiss TPH) > Department of Medical Parasitology and Infection Biology (MPI) > Helminth Drug Development (Keiser)
UniBasel Contributors:Manneck, Theresia and Keiser, Jennifer
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Related URLs:
Identification Number:
Last Modified:08 Nov 2012 16:22
Deposited On:08 Nov 2012 16:12

Repository Staff Only: item control page